C26H42O9
Neat
498.62
Pseudomonic acid D; 85248-93-7; UNII-68IC2993TO; 68IC2993TO; (E)-9-[(E)-4-[(2S, 3R, 4R, 5S)-3, 4-dihydroxy-5-[[(2S, 3S)-3-[(2S, 3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynon-4-enoic acid; Mupirocin calcium specified impurity C [EP]; PSEUDOMONIC ACID D [MI]; (4E)-9-(((2E)-4-((2S, 3R, 4R, 5S)-3, 4-Dihydroxy-5-(((2S, 3S)3-((1S, 2S)-2-hydroxy-1-methylpropyl)oxiranyl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)non-4-enoic acid; L-TALO-NON-2-enonic acid, 5, 9-anhydro-2, 3, 4, 8-tetradeoxy-8-(((2S, 3S)-3-((1S, 2S)-2-hydroxy-1-methylpropyl)oxiranyl)methyl)-3-methyl-, (5E)-8-carboxy-5-octenyl ester, (2E)-; MUPIROCIN IMPURITY C [EP IMPURITY]; MUPIROCIN CALCIUM IMPURITY C [EP IMPURITY]; MUPIROCIN IMPURITY C (EP IMPURITY); MUPIROCIN CALCIUM IMPURITY C (EP IMPURITY); Mupirocin calcium impurity, pseudomonic acid D-(USP); Mupirocin calcium impurity, pseudomonic acid D-[USP]; Pseudomonate D; MUPIROCIN CALCIUM IMPURITY, PSEUDOMONIC ACID D-(USP IMPURITY); MUPIROCIN CALCIUM IMPURITY, PSEUDOMONIC ACID D-[USP IMPURITY]; (E)-9-((E)-4-((2S, 3R, 4R, 5S)-3, 4-dihydroxy-5-(((2S, 3S)-3-((2S and 3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)oxan-2-yl)-3-methylbut-2-enoyl)oxynon-4-enoic acid; RefChem:176952
(E)-9-[(E)-4-[(2S, 3R, 4R, 5S)-3, 4-dihydroxy-5-[[(2S, 3S)-3-[(2S and 3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynon-4-enoic acid
InChI=1S/C26H42O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27/h4,6,13,17-21,24-27,31-32H,5,7-12,14-15H2,1-3H3,(H,28,29)/b6-4+,16-13+/t17-,18-,19-,20-,21-,24+,25-,26-/m0/s1